A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
Prescient Therapeutics, Ltd.
Prescient Therapeutics, Ltd.
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
March Biosciences Inc
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
The Lymphoma Academic Research Organisation
Masonic Cancer Center, University of Minnesota
Yale University
The First Affiliated Hospital of Xiamen University
Keimyung University Dongsan Medical Center